Sunali Y Mehta

14PUBLICATIONS

38CO-AUTHORS

Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiological adaptation

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 05, 2026

TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion.

|May 27, 2026

YBX1 Expression Marks Proliferative Tumour States with Context-Dependent Genomic Instability: A Pan-Cancer Analysis.

|Dec 30, 2025

<i>TP53</i> Splice Mutations Have Tumour-Independent Effects on Genomic Stability and Prognosis: An In Silico Study.

Apeksha Arun Bhandarkar, Noah Ethan Kelly-Foleni, Debina Sarkar

|Aug 29, 2025

Δ133p53 isoform enhances TLR4 function to promote tumor growth.

Sasini Polwatta Lekamlage, Alexandra N Boix De Jesus, Adriana Machado Saraiva

|Jan 21, 2023

Increased Expression of the Δ133p53β Isoform Enhances Brain Metastasis.

Alexandra N Boix De Jesus, Ahmad Taha, David Wang

|Oct 18, 2022

Impact of Clinical Data Veracity on Cancer Genomic Research.

Sunali Mehta, Deborah Wright, Michael A Black

Pageof 3

Frequent Collaborators

Tania Slatter

Cushla McKinney

Debina Sarkar

Antony W Braithwaite

Adele G Woolley

Noha Ahmed Nasef

Cristin Print

Annette Lasham

Janice Royds

Karen Reader

Frequent Collaborators

Tania Slatter

Cushla McKinney

Debina Sarkar

Antony W Braithwaite